文献速递间质性肺疾病肺栓塞与肺血管病

肺朗格汉斯细胞组织细胞增生症的运动限制机制与肺动脉高压患病率

Mechanisms of Exercise Limitation and Prevalence of Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis.
PubMed 文献 · Chest · 2020-06-29

结果显示运动限制多为多因素(71%),通气与循环限制常见,肺动脉高压(PH)患病率41%,以毛细血管前型为主。

要点

  • PLCH患者运动能力下降常见,运动限制常为多因素(71%)。
  • PH患病率41%,以毛细血管前型为主。
  • FEV1和DLCO是运动能力的良好预测指标。

核心结论

  • PLCH患者中PH常见且运动受损普遍,运动限制多为多因素。
  • 最常见的运动限制机制为通气限制、循环限制及提示PH的限制。

研究设计与样本

  • 患者接受递增跑台心肺运动试验评估动态肺过度充气(DH)、肺功能及经胸超声心动图。
  • DLCO<40%预计值和/或三尖瓣反流速度>2.5 m/s和/或间接PH征象者行右心导管检查。

主要发现

  • 通气限制、循环限制、提示PH的损害及气体交换受损分别见于88%、67%、29%、88%的患者。
  • 运动限制为多因素者占71%,运动能力下降者占71%,DH发生率为68%。
  • FEV1为64±22%预计值,DLCO为56±21%预计值。
  • DLCO下降、阻塞性通气模式及气体陷闭分别见于80%、77%、37%的患者。
  • PH患病率为41%,以毛细血管前型为主,平均肺动脉压与FEV1及三尖瓣反流速度相关性最好。

关键数值与推荐

  • DLCO<40%预计值和/或三尖瓣反流速度>2.5 m/s和/或间接PH征象时行右心导管检查。
  • FEV1和DLCO是运动能力的良好预测指标。

临床怎么用

  • 对PLCH患者应评估运动限制的多因素机制,包括通气、循环及PH。
  • DLCO显著下降或超声提示PH时应考虑右心导管检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary Langerhans cell histiocytosis (PLCH) determines reduced exercise capacity. The speculated mechanisms of exercise impairment in PLCH are ventilatory and cardiocirculatory limitations, including pulmonary hypertension (PH). RESEARCH QUESTION: What are the mechanisms of exercise limitation, the exercise capacity, and the prevalence of dynamic hyperinflation (DH) and PH in PLCH? STUDY DESIGN AND METHODS: In a cross-sectional study, patients with PLCH underwent an incremental treadmill cardiopulmonary exercise test with an evaluation of DH, pulmonary function tests, and transthoracic echocardiography. Those patients with lung diffusing capacity for carbon monoxide (Dlco) < 40% predicted and/or transthoracic echocardiogram with tricuspid regurgitation velocity > 2.5 m/s and/or with indirect PH signs underwent right heart catheterization. RESULTS: Thirty-five patients were included (68% women; mean age, 47 ± 11 years). Ventilatory and cardiocirculatory limitations, impairment suggestive of PH, and impaired gas exchange occurred in 88%, 67%, 29%, and 88% of patients, respectively. The limitation was multifactorial in 71%, exercise capacity was reduced in 71%, and DH occurred in 68% of patients. FEV1 and Dlco were 64 ± 22% predicted and 56 ± 21% predicted. Reduction in Dlco, an obstructive pattern, and air trapping occurred in 80%, 77%, and 37% of patients. FEV1 and Dlco were good predictors of exercise capacity. The prevalence of PH was 41%, predominantly with a precapillary pattern, and mean pulmonary artery pressure correlated best with FEV1 and tricuspid regurgitation velocity. INTERPRETATION: PH is frequent and exercise impairment is common and multifactorial in PLCH. The most prevalent mechanisms are ventilatory, cardiocirculatory, and suggestive of PH limitations. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT02665546; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Heiden GI, Sobral JB, Freitas CSG, et al. Mechanisms of Exercise Limitation and Prevalence of Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis. Chest. 2020. PMID: 32615192. doi:10.1016/j.chest.2020.05.609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。